Skin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio Strategy - Motley Fool

Skin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio Strategy Motley Fool GlaxoSmithKline (NYSE: GSK ) dermatology and skin subsidiary Stiefel has submitted to regulators a new drug application for tazarotene foam, an acne skin care treatment product. If approved by the US Food ... Skin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio StrategyDailyFinance all 3 news articles »

Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIgmR7VsXuTshepOa6zrwuE3cyaw&url=http://www.fool.com/investing/general/2011/08/04/skin-in-the-game-how-acne-skin-care-fits-gsks-drug.aspx

stretch marks removal pregnancy skin care tip woman care woman health